Experience of anti-retroviral treatment for HIV-infected children in Malawi: The 1st 12 months

Annals of Tropical Paediatrics

Volumn 27, Issue 4, 2007, Pages 261-267

  Ellis, Jane C ^a,b   Molyneux, Elizabeth M ^a  

^a UNIVERSITY OF MALAWI   (Malawi)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; LAMIVIR S; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LAMIVUDINE PLUS STAVUDINE; TRIOMUNE 40; UNCLASSIFIED DRUG;

CHILD HEALTH; DISEASE TREATMENT; HUMAN IMMUNODEFICIENCY VIRUS; VIRAL DISEASE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BODY HEIGHT; BODY WEIGHT; CHILD; CHILDHOOD MORTALITY; CONTROLLED STUDY; DATA COLLECTION METHOD; DEMOGRAPHY; DIZZINESS; DRUG ERUPTION; DRUG FATALITY; DRUG FORMULATION; DRUG WITHDRAWAL; EVENING DOSAGE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HEALTH CARE MANPOWER; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LACTIC ACIDOSIS; MAJOR CLINICAL STUDY; MALAWI; MALE; MORNING DOSAGE; PANCREATITIS; PATIENT COMPLIANCE; PATIENT TRANSPORT; PRESCRIPTION; PUBLIC HOSPITAL; SCORING SYSTEM; STAGING; STEVENS JOHNSON SYNDROME;

ADOLESCENT; ANTHROPOMETRY; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INFANT; MALAWI; MALE; PUBLIC SECTOR; TREATMENT OUTCOME;

AFRICA; EAST AFRICA; MALAWI; SUB-SAHARAN AFRICA;

EID: 36448935298     PISSN: 02724936     EISSN: None     Source Type: Journal    
DOI: 10.1179/146532807X245643     Document Type: Article

References (17)

1. World Health Organization. Progress on Global Access to HIV Antirotroviral Therapy. An Update on "3 by 5". Geneva: WHO, June 2005.
2. UNAIDS. Report on the Global HIV/AIDS Epidemic. WHO, 2006.
3. National AIDS Commission. National Estimate of HIV/AIDS in Malawi in 2003. Lilongwe, Malawi, 2003.
4. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Galliard P, Dabis F. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004; 364:1236-43.
5. van Oosterhout JJ, Bodasing N, Kumwenda JJ, et al. Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi. Trop Med Int Health 2005; 10:464-70.
6. Ministry of Health, Malawi. Treatment of AIDS: Guidelines for the Use of Antiretroviral Therapy in Malawi, 1st edn. Lilongwe, October 2003.
7. UNICEF/WHO Technical Consultation. Improving Access to Appropriate Paediatric ARV Formulations. Geneva: WHO, November 2004.
8. World Health Organization. Scaling up Antiretroviral Therapy in Resource-Limited Settings: Treatment Guidelines for a Public Health Approach, 2003 revision. Geneva: WHO, 2004.
9. Rogerson SR, Gladstone M, Callaghan M, et al. HIV infection among paediatric in-patients in Blantyre, Malawi. Trans R Soc Trap Med Hyg 2004; 98:544-52.
10. World Health Organization, UNAIDS, UNICEF. Joint Statement on the Use of Cotrimoxazole as Prophylaxis in HIV Exposed and HIV Infected Children. Geneva: WHO, 2004.
11. Eley B, Nuttall J, Davies MA, et al. Initial experience of a public sector antiretroviral treatment programme for HIV-infected children and theft infected parents. S Aft Med J 2004; 94:643-6.
12. Fassinou P, Elenga N, Rouet F, et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d'Ivoire. AIDS 2004; 18:1905-13.
13. Barlow-Mosha L, Musoke P, Ajuna P, et al. Early effectiveness of Triomune in HIV-infected Ugandan children. Third International AIDS Society Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, 2005; abstract WeOa0103.
14. World Health Organization. Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-Related Disease in Adults and Children. Geneva: WHO, August 2006
15. Walker AS, Mulenga V, Sinyinza F, et al. Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial. J Acquir Immune Defic Syndr 2006; 42:637-45.
16. Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Pediatrics 2002; 109:E25
17. Ellis JC, L'Homme RFA, Ewings FM, et al. Nevirapine concentrations in HIV-infected children treated with divided fixed dose combination tablets in Malawi and Zambia. Antivir Ther 2007; 12:253-60.